iRhythm Technologies
San Francisco
About iRhythm Technologies
iRhythm provides innovative and cost-effective diagnostic monitoring solutions that facilitate early diagnosis and treatment decisions, with the goal of ultimately improving patient health outcomes and reducing wasteful healthcare spending. Its flagship product, the Zio® Patch, is designed to optimize and simplify the diagnosis of cardiac arrhythmias. Zio® Patch is the smallest, lightest, least conspicuous cardiac arrhythmia diagnostic available and is indicated for up to 14-day monitoring.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $500K – $1M
- Total funding: $1.2B
- Funding stage: IPO
- Last round: Post-IPO Debt (Mar 2024)
- Ticker: nasdaq:IRTC
- Website: irhythmtech.com
- Phone: (415) 632-5700
Industries & Categories
Health Care, Health Diagnostics, Medical Device, mHealth, Wearables
Social Profiles
Canonical: https://fsome.com/organization/irhythm-technologies-2242 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.